RE: For comparisonIf your forcasts re. potential revenue are correct and if the stock gets thru 2.00 soon along with any positive news the company may turn into a very successful biotech. With all the takeovers of large cap Canadian companies their is lots of money looking for great stories in the Canadian market. Management deserves lotsa of credit for builing a company with lots of potential with very little dillution.